APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perennial Allergic Rhinitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Perennial Allergic Rhinitis Drug Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchPerennial Allergic Rhinitis Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Perennial Allergic Rhinitis Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Perennial Allergic Rhinitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perennial Allergic Rhinitis Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Perennial Allergic Rhinitis Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Perennial Allergic Rhinitis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Perennial Allergic Rhinitis Drug include Merck & Co., Inc., Pfizer Inc., VentiRx Pharmaceuticals, Inc., Shionogi & Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Glenmark Pharmaceuticals Ltd. and Faes Farma, S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Perennial Allergic Rhinitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Perennial Allergic Rhinitis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Perennial Allergic Rhinitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Perennial Allergic Rhinitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Perennial Allergic Rhinitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Perennial Allergic Rhinitis Drug Market by Company

Merck & Co., Inc.

Pfizer Inc.

VentiRx Pharmaceuticals, Inc.

Shionogi & Co., Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Glenmark Pharmaceuticals Ltd.

Faes Farma, S.A.

Perennial Allergic Rhinitis Drug Segment by Type

APC-3000

Bilastine

Desloratadine

Asapiprant

Others

Perennial Allergic Rhinitis Drug Segment by Application

Clinic

Hospital

Others

Perennial Allergic Rhinitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perennial Allergic Rhinitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perennial Allergic Rhinitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perennial Allergic Rhinitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Perennial Allergic Rhinitis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Perennial Allergic Rhinitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of APC-3000 Table 2. Major Company of Bilastine Table 3. Major Company of Desloratadine Table 4. Major Company of Asapiprant Table 5. Major Company of Others Table 6. Global Perennial Allergic Rhinitis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Perennial Allergic Rhinitis Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Perennial Allergic Rhinitis Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Perennial Allergic Rhinitis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Perennial Allergic Rhinitis Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Perennial Allergic Rhinitis Drug Industry Trends Table 28. Perennial Allergic Rhinitis Drug Industry Drivers Table 29. Perennial Allergic Rhinitis Drug Industry Opportunities and Challenges Table 30. Perennial Allergic Rhinitis Drug Industry Restraints Table 31. Global Perennial Allergic Rhinitis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Perennial Allergic Rhinitis Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Perennial Allergic Rhinitis Drug Sales Share by Company (2021-2026) Table 35. Global Perennial Allergic Rhinitis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Perennial Allergic Rhinitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Perennial Allergic Rhinitis Drug Major Company Production Sites and Headquarters Table 38. Global Perennial Allergic Rhinitis Drug Company, Product Type & Application Table 39. Global Perennial Allergic Rhinitis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Perennial Allergic Rhinitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Perennial Allergic Rhinitis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Perennial Allergic Rhinitis Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Perennial Allergic Rhinitis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Perennial Allergic Rhinitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Perennial Allergic Rhinitis Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Perennial Allergic Rhinitis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Perennial Allergic Rhinitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Perennial Allergic Rhinitis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Perennial Allergic Rhinitis Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Perennial Allergic Rhinitis Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Perennial Allergic Rhinitis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Perennial Allergic Rhinitis Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. Pfizer Inc. Company Information Table 80. Pfizer Inc. Business Overview Table 81. Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 83. Pfizer Inc. Recent Development Table 84. VentiRx Pharmaceuticals, Inc. Company Information Table 85. VentiRx Pharmaceuticals, Inc. Business Overview Table 86. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 88. VentiRx Pharmaceuticals, Inc. Recent Development Table 89. Shionogi & Co., Ltd. Company Information Table 90. Shionogi & Co., Ltd. Business Overview Table 91. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product Portfolio Table 93. Shionogi & Co., Ltd. Recent Development Table 94. Hisamitsu Pharmaceutical Co., Inc. Company Information Table 95. Hisamitsu Pharmaceutical Co., Inc. Business Overview Table 96. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 98. Hisamitsu Pharmaceutical Co., Inc. Recent Development Table 99. Glenmark Pharmaceuticals Ltd. Company Information Table 100. Glenmark Pharmaceuticals Ltd. Business Overview Table 101. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product Portfolio Table 103. Glenmark Pharmaceuticals Ltd. Recent Development Table 104. Faes Farma, S.A. Company Information Table 105. Faes Farma, S.A. Business Overview Table 106. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product Portfolio Table 108. Faes Farma, S.A. Recent Development Table 109. North America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. North America Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 111. North America Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2026) Table 112. North America Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 113. North America Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Country (2027-2032) Table 114. North America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Perennial Allergic Rhinitis Drug Market Share by Country (2021-2026) Table 117. North America Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Perennial Allergic Rhinitis Drug Market Share Forecast by Country (2027-2032) Table 119. Europe Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Europe Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 121. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2026) Table 122. Europe Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 123. Europe Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Perennial Allergic Rhinitis Drug Market Share by Country (2021-2026) Table 127. Europe Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Perennial Allergic Rhinitis Drug Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 131. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 133. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Perennial Allergic Rhinitis Drug Market Share by Country (2021-2026) Table 137. Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Perennial Allergic Rhinitis Drug Market Share Forecast by Country (2027-2032) Table 139. Latin America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Latin America Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 141. Latin America Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2026) Table 142. Latin America Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 143. Latin America Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Perennial Allergic Rhinitis Drug Market Share by Country (2021-2026) Table 147. Latin America Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Perennial Allergic Rhinitis Drug Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 151. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 153. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Perennial Allergic Rhinitis Drug Market Share by Country (2021-2026) Table 157. Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Perennial Allergic Rhinitis Drug Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Perennial Allergic Rhinitis Drug Distributors List Table 162. Perennial Allergic Rhinitis Drug Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Perennial Allergic Rhinitis Drug Image Figure 2. Global Perennial Allergic Rhinitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perennial Allergic Rhinitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Perennial Allergic Rhinitis Drug Sales (2021-2032) & (K Units) Figure 5. APC-3000 Image Figure 6. Global APC-3000 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bilastine Image Figure 8. Global Bilastine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Desloratadine Image Figure 10. Global Desloratadine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Asapiprant Image Figure 12. Global Asapiprant Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Perennial Allergic Rhinitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Perennial Allergic Rhinitis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Perennial Allergic Rhinitis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Perennial Allergic Rhinitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Perennial Allergic Rhinitis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Perennial Allergic Rhinitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Perennial Allergic Rhinitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Perennial Allergic Rhinitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Perennial Allergic Rhinitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Perennial Allergic Rhinitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Perennial Allergic Rhinitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Perennial Allergic Rhinitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Perennial Allergic Rhinitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Perennial Allergic Rhinitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Perennial Allergic Rhinitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Perennial Allergic Rhinitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Perennial Allergic Rhinitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Perennial Allergic Rhinitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Perennial Allergic Rhinitis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Perennial Allergic Rhinitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • APC-3000
  • Bilastine
  • Desloratadine
  • Asapiprant
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Merck & Co., Inc.
  • Pfizer Inc.
  • VentiRx Pharmaceuticals, Inc.
  • Shionogi & Co., Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Faes Farma, S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Perennial Allergic Rhinitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Perennial Allergic Rhinitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Perennial Allergic Rhinitis Drug Market by Type
  6. 1.3.1 APC-3000
  7. 1.3.2 Bilastine
  8. 1.3.3 Desloratadine
  9. 1.3.4 Asapiprant
  10. 1.3.5 Others
  11. 1.4 Global Perennial Allergic Rhinitis Drug Market Size by Type
  12. 1.4.1 Global Perennial Allergic Rhinitis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Perennial Allergic Rhinitis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Perennial Allergic Rhinitis Drug Industry Trends
  2. 2.2 Perennial Allergic Rhinitis Drug Industry Drivers
  3. 2.3 Perennial Allergic Rhinitis Drug Industry Opportunities and Challenges
  4. 2.4 Perennial Allergic Rhinitis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Perennial Allergic Rhinitis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Perennial Allergic Rhinitis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Perennial Allergic Rhinitis Drug Price (2021-2026)
  4. 3.4 Global Perennial Allergic Rhinitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Perennial Allergic Rhinitis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Perennial Allergic Rhinitis Drug Company, Product Type & Application
  7. 3.7 Global Perennial Allergic Rhinitis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Perennial Allergic Rhinitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Perennial Allergic Rhinitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Perennial Allergic Rhinitis Drug Tier 1, Tier 2, and Tier 3
4 Perennial Allergic Rhinitis Drug Regional Status and Outlook
  1. 4.1 Global Perennial Allergic Rhinitis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Perennial Allergic Rhinitis Drug Historic Market Size by Region
  3. 4.2.1 Global Perennial Allergic Rhinitis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Perennial Allergic Rhinitis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Perennial Allergic Rhinitis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Perennial Allergic Rhinitis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Perennial Allergic Rhinitis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Perennial Allergic Rhinitis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Perennial Allergic Rhinitis Drug by Application
  1. 5.1 Perennial Allergic Rhinitis Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Perennial Allergic Rhinitis Drug Market Size by Application
  6. 5.2.1 Global Perennial Allergic Rhinitis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Perennial Allergic Rhinitis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Perennial Allergic Rhinitis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 VentiRx Pharmaceuticals, Inc.
  14. 6.3.1 VentiRx Pharmaceuticals, Inc. Company Information
  15. 6.3.2 VentiRx Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  18. 6.3.5 VentiRx Pharmaceuticals, Inc. Recent Developments
  19. 6.4 Shionogi & Co., Ltd.
  20. 6.4.1 Shionogi & Co., Ltd. Company Information
  21. 6.4.2 Shionogi & Co., Ltd. Business Overview
  22. 6.4.3 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
  24. 6.4.5 Shionogi & Co., Ltd. Recent Developments
  25. 6.5 Hisamitsu Pharmaceutical Co., Inc.
  26. 6.5.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
  27. 6.5.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
  28. 6.5.3 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  30. 6.5.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments
  31. 6.6 Glenmark Pharmaceuticals Ltd.
  32. 6.6.1 Glenmark Pharmaceuticals Ltd. Company Information
  33. 6.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
  34. 6.6.3 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
  36. 6.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
  37. 6.7 Faes Farma, S.A.
  38. 6.7.1 Faes Farma, S.A. Company Information
  39. 6.7.2 Faes Farma, S.A. Business Overview
  40. 6.7.3 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product Portfolio
  42. 6.7.5 Faes Farma, S.A. Recent Developments
7 North America by Country
  1. 7.1 North America Perennial Allergic Rhinitis Drug Sales by Country
  2. 7.1.1 North America Perennial Allergic Rhinitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Perennial Allergic Rhinitis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Perennial Allergic Rhinitis Drug Market Size by Country
  6. 7.2.1 North America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Perennial Allergic Rhinitis Drug Sales by Country
  2. 8.1.1 Europe Perennial Allergic Rhinitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Perennial Allergic Rhinitis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Perennial Allergic Rhinitis Drug Market Size by Country
  6. 8.2.1 Europe Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Perennial Allergic Rhinitis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Perennial Allergic Rhinitis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Perennial Allergic Rhinitis Drug Sales by Country
  2. 10.1.1 South America Perennial Allergic Rhinitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Perennial Allergic Rhinitis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Perennial Allergic Rhinitis Drug Market Size by Country
  6. 10.2.1 South America Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Perennial Allergic Rhinitis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Perennial Allergic Rhinitis Drug Value Chain Analysis
  2. 12.1.1 Perennial Allergic Rhinitis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Perennial Allergic Rhinitis Drug Production Mode & Process
  7. 12.2 Perennial Allergic Rhinitis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Perennial Allergic Rhinitis Drug Distributors
  10. 12.2.3 Perennial Allergic Rhinitis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst